David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$454M |
| 2 |
Apple
AAPL
|
+$364M |
| 3 |
Procter & Gamble
PG
|
+$314M |
| 4 |
Verizon
VZ
|
+$308M |
| 5 |
Pfizer
PFE
|
+$299M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$735M |
| 2 |
Emerson Electric
EMR
|
+$423M |
| 3 |
Biogen
BIIB
|
+$354M |
| 4 |
PayPal
PYPL
|
+$349M |
| 5 |
Amazon
AMZN
|
+$338M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.34% |
| 2 | Healthcare | 11.75% |
| 3 | Consumer Discretionary | 9.24% |
| 4 | Financials | 7.7% |
| 5 | Communication Services | 6.29% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3376
PUT
Allegion
ALLE
$13.8B
| $304K | ﹤0.01% |
+3,300
| New | +$395K |
|
|
TGH
3377
DELISTED
Textainer Group Holdings limited
TGH
| $304K | ﹤0.01% |
36,932
-103,261
| -74% | -$943K |
|
|
BSTC
3378
DELISTED
BioSpecifics Technologies Corp.
BSTC
| $304K | ﹤0.01% |
5,369
-1,400
| -21% | -$79.8K |
|
3379
MarineMax
HZO
$1.15B
| $302K | ﹤0.01% |
+28,990
| New | +$472K |
|
|
SUP
3380
DELISTED
Superior Industries International
SUP
| $302K | ﹤0.01% |
251,781
-90,959
| -27% | -$240K |
|
3381
Wave Life Sciences
WVE
$1.01B
| $301K | ﹤0.01% |
32,112
+9,564
| +42% | +$81.5K |
|
|
XIFR
3382
XPLR Infrastructure LP
XIFR
$1.06B
| $301K | ﹤0.01% |
+7,000
| New | +$371K |
|
|
EBIX
3383
PUT
DELISTED
Ebix Inc
EBIX
| $301K | ﹤0.01% |
19,800
-86,200
| -81% | -$2.46M |
|
3384
Culp Inc
CULP
$43.9M
| $300K | ﹤0.01% |
40,770
+2,213
| +6% | +$23.9K |
|
3385
Fidus Investment
FDUS
$752M
| $300K | ﹤0.01% |
45,385
+33,273
| +275% | +$430K |
|
3386
BancFirst
BANF
$3.78B
| $299K | ﹤0.01% |
+8,974
| New | +$467K |
|
3387
XBiotech
XBIT
$70.4M
| $298K | ﹤0.01% |
28,105
-147,684
| -84% | -$2.4M |
|
3388
CALL
Travel + Leisure Co
TNL
$4.48B
| $297K | ﹤0.01% |
13,700
| – | – |
|
|
Y
3389
DELISTED
Alleghany Corp
Y
| $297K | ﹤0.01% |
537
-454
| -46% | -$327K |
|
|
BNY
3390
CALL
Bank of New York Mellon
BNY
$110B
| $296K | ﹤0.01% |
8,800
-65,100
| -88% | -$2.73M |
|
|
DX
3391
Dynex Capital
DX
$3.24B
| $296K | ﹤0.01% |
28,375
-7,646
| -21% | -$126K |
|
3392
First Merchants
FRME
$2.63B
| $296K | ﹤0.01% |
+11,162
| New | +$407K |
|
3393
Gerdau
GGB
$8.5B
| $296K | ﹤0.01% |
+195,329
| New | +$619K |
|
|
GOOD
3394
Gladstone Commercial Corp
GOOD
$638M
| $296K | ﹤0.01% |
+20,606
| New | +$392K |
|
3395
PUT
Core Laboratories
CLB
$553M
| $295K | ﹤0.01% |
28,500
+19,700
| +224% | +$551K |
|
3396
Medifast
MED
$134M
| $294K | ﹤0.01% |
+4,707
| New | +$429K |
|
|
CMA
3397
PUT
DELISTED
Comerica
CMA
| $293K | ﹤0.01% |
10,000
-12,600
| -56% | -$684K |
|
|
VNE
3398
PUT
DELISTED
Veoneer, Inc.
VNE
| $293K | ﹤0.01% |
40,000
-72,100
| -64% | -$860K |
|
3399
PUT
Centene
CNC
$32.4B
| $291K | ﹤0.01% |
4,900
-574,300
| -99% | -$34.8M |
|
|
UNVR
3400
DELISTED
Univar Solutions Inc.
UNVR
| $291K | ﹤0.01% |
+27,127
| New | +$503K |
|
Similar funds
David Shaw's Q1 2020 Portfolio in Review
As of Q1 2020, David Shaw held 4,498 positions worth $64.1B, down 27% from $87.5B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
David Shaw withdrew a net $5.59B in Q1 2020, closing 626 positions and reducing 1,723 holdings. Its most notable exit was PG&E, an estimated $79M position sold in full.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 16% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, David Shaw opened a new position in iShares iBoxx $ Investment Grade Corporate Bond ETF worth $124M.
- David Shaw's largest Q1 2020 buy was iShares iBoxx $ Investment Grade Corporate Bond ETF: 1,005,000 shares worth $124M.
- David Shaw added most to ExxonMobil in Q1 2020, an estimated $454M increase.
- David Shaw's biggest Q1 2020 reduction was Tesla, cutting an estimated $735M.
- David Shaw fully exited PG&E in Q1 2020, selling an estimated $79M.
- David Shaw's ten largest holdings make up 12% of its $64.1B portfolio in Q1 2020.
- David Shaw opened 538 new positions and closed 626 in Q1 2020.
- David Shaw's portfolio value fell 27% quarter-over-quarter to $64.1B.
Based on D.E. Shaw & Co's 13F filing for Q1 2020, filed 15 May 2020.